Understanding diabetes is the first crucial step in its management and prevention. In today's context, diabetes is widely acknowledged as a chronic, progressive metabolic disorder that impairs the body's ability to utilize glucose effectively.
Despite advancements in drug development, there are notable shortcomings in the currently available treatments for type 2 diabetes mellitus. The global diabetes crisis persists, even with the introduction of new drug types and targets. Moreover, existing medications for type 2 diabetes have demonstrated significant limitations and undesirable side effects.
In honor of World Diabetes Day 2023, Life Chemicals is proud to offer its exclusive collection of dedicated Screening Compound Libraries to support ongoing efforts in diabetes-related drug development:
- RNA Focused and Targeted Libraries
- Transcription-related Screening Library
- Nuclear Receptor Screening Libraries
- SH2 Domain Focused Library
- Anti-inflammatory Screening Compound Library
Please, contact us at orders@lifechemicals.com for any additional information and price quotations.
Visit our Website for a detailed product description, or place an order online on our E-commerce website.
Download SD files with compound structures directly from our Downloads section
Custom compound selection based on specific parameters can be performed on request, with competitive pricing and the most convenient terms provided.